-
KIF18A Targeting Therapies FDA EMA Approval Clinical Trials By Indication Company Country Drug Class Report
12 Jul 2025 09:18 GMT
… -genome doubling, and has received FDA Fast Track status—accelerating its …
-
Ultragenyx Receives Complete Response Letter from FDA for UX111 AAV Gene Therapy to Treat Sanfilippo Syndrome Type A (MPS IIIA)
11 Jul 2025 20:30 GMT
… observations that are resolvable FDA clinical reviews acknowledged that the … that the U.S. Food and Drug Administration (FDA) has issued a Complete … been ongoing and the FDA has acknowledged that the … to the satisfaction of the FDA, the development, timing …
-
Cancer Antibody Drug Conjugates Treatment Market Size Clinical Trials FDA Approved Report
11 Jul 2025 18:16 GMT
Delhi, July 11, 2025 (GLOBE NEWSWIRE) -- Global Cancer Antibody Drug Conjugates Market Size, Drugs Approval, Price, Sales and Clinical Trials Insight 2030 Report Finding & Inclusions:
Global Cancer Antibody Drug Conjugates Market: 2020 – 2030
Global …
-
Bispecific Antibody Drug Conjugates Clinical Trials FDA Approval Market Trends Report
11 Jul 2025 17:22 GMT
Delhi, July 11, 2025 (GLOBE NEWSWIRE) -- Global Bispecific Antibody Drug Conjugates Clinical Trials, Regulatory Approvals and Future Market Opportunity Outlook 2029 Report:
Report Answers Question On Why There Exist Need For Bispecific Antibody Drug …
-
STAT+: Pharmalittle: We’re reading about a FDA offer on drug reviews, a Moderna Covid approval, and more
11 Jul 2025 15:01 GMT
… . See you soon. …
U.S. Food and Drug Administration Commissioner Marty Makary said the … of a new program the FDA announced last month that would … children has been given full FDA approval, making it the first … issued a license by the FDA for use in people 12 …
-
STAT+: FDA rejects Capricor’s cell therapy for Duchenne muscular dystrophy
11 Jul 2025 15:01 GMT
The Food and Drug Administration rejected a marketing application from … its letter to Capricor, the FDA said the company’s application … a marketing application to the FDA at the end of December …
-
STAT+: Questions about the FDA’s ‘radical transparency’ efforts
11 Jul 2025 15:01 GMT
… at CIRM, and about the FDA’s move to release a … batch of complete response letters.
FDA rejects Capricor’s cell therapy … my colleague Adam Feuerstein: The Food and Drug Administration rejected a marketing application from …
-
Cancer Photodynamic Therapy Clinical Trials Market Size FDA Approval Market Report Insight
11 Jul 2025 16:41 GMT
… example is Sun Pharmaceutical’s FDA cleared BLU-U Blue Light …
-
FDA Issues Risk Warning as Apples Recalled in Four States
11 Jul 2025 14:44 GMT
… given by the U.S. Food and Drug Administration (FDA).
United Natural Foods, Inc., … a reach truck. The FDA subsequently issued a Class II … remote," according to the FDA.
The Agency for Toxic … as ongoing, according to the FDA. Consumers who may have …
-
“Radical Transparency” or Not? FDA Releases Hundreds of Decision Letters to the Public
11 Jul 2025 14:03 GMT
… “embrace radical transparency”, the US Food and Drug Administration (FDA) has made over 200 complete … letters publicly available.
“The FDA issues CRLs for various reasons … recommendations for addressing them,” an FDA statement reads.
Daily Breaking Science …